EVerZom
PrivateLast Round
Series A
Oct 14, 2025
Est. Valuation
$27.15M
Total Funding Raised
$19.15M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
EVerZom operates in Healthcare & Life Sciences and is based in Paris. Its latest recorded funding round was a Series A round in October 2025.
EVerZom is a biotechnology company that develops a biomanufacturing platform for exosome-based therapies for regenerative medicine applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
EVerZom Comparables
Compare EVerZom with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| EXO Biologics | 88% | |
| Curexsys GmbH | 85% | |
| BREXOGEN Inc. | 80% |
For institutional investors. Book with your work email.
EVerZom Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Oct 14, 2025 | ||||
| Grant | Jun 17, 2025 | ||||
| Grant | Nov 18, 2021 | ||||
| Seed | Nov 30, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
EVerZom Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Grant, Series A |
| Paris Business Angels | Series A |
| Capital Grand Est | Series A |
| Sorbonne Venture | Series A |
| Bpifrance | Grant |
| Capital Cell | Series A |
| Aloe Private Equity | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 13, 2026
Open roles increased from 0 to 10, representing 45% of headcount.
- Jan 7, 2026
Monthly visitors grew 579% MoM, reaching 2.3K.
For institutional investors. Book with your work email.
EVerZom Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about EVerZom's valuation, stock price, and market status.
Is EVerZom a public or private company?
EVerZom is a private company.
What is the current stock price of EVerZom?
EVerZom is a private company, so its shares have no public market price. Caplight tracks EVerZom's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is EVerZom worth (valuation)?
EVerZom's valuation is estimated at $27.2M based on funding round data.
Can I buy EVerZom stock?
EVerZom shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was EVerZom's last funding round?
EVerZom's most recent funding round was Series A on October 14, 2025.
Who are the main investors in EVerZom?
Key investors in EVerZom include Capital Grand Est.
Will EVerZom IPO soon?
No public IPO plans have been announced for EVerZom.
How can I track EVerZom secondary market activity?
Caplight tracks bids, offers, and trades in EVerZom's shares on secondary markets.